BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15705062)

  • 41. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma.
    Honma H; Kanda T; Ito H; Wakai T; Nakagawa S; Ohashi M; Koyama Y; Valera VA; Akazawa K; Hatakeyama K
    Surgery; 2006 May; 139(5):678-85. PubMed ID: 16701102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Etiology and prognosis of penile neoplasms].
    Feustel A; Zochert G; Bellmann H
    Z Urol Nephrol; 1972 Sep; 65(9):687-94. PubMed ID: 4649683
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical effects of concurrent chemoradiotherapy (hyperfractionation and cisplatin/5-fluorouracil) for patients with advanced oral squamous cell carcinoma].
    Tsuchiya Y; Noguchi T; Matsumoto K; Matsumura T; Hoshi K; Ito H; Osano H; Jinbu Y; Kusama M
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):101-3. PubMed ID: 19151572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
    Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cancer of the penis].
    Glozman VN
    Vestn Dermatol Venerol; 1984 Jan; (1):44-5. PubMed ID: 6702293
    [No Abstract]   [Full Text] [Related]  

  • 46. Biochemical prognostic factors and risk of relapses in patients with cervical cancer.
    Gadducci A; Tana R; Fanucchi A; Genazzani AR
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S23-6. PubMed ID: 17727924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Carcinoma of the penis].
    Schindler E; May P
    Med Welt; 1973 Aug; 24(31):1205-7. PubMed ID: 4746420
    [No Abstract]   [Full Text] [Related]  

  • 48. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
    Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
    Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients.
    Giannelli G; Fransvea E; Trerotoli P; Beaugrand M; Marinosci F; Lupo L; Nkontchou G; Dentico P; Antonaci S
    Clin Chim Acta; 2007 Aug; 383(1-2):147-52. PubMed ID: 17582392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study.
    Niibe Y; Kazumoto T; Toita T; Yamazaki H; Higuchi K; Ii N; Suzuki K; Uno T; Tokumaru S; Takayama M; Sekiguchi K; Matsumoto Y; Michimoto K; Oguchi M; Hayakawa K
    Gynecol Oncol; 2006 Nov; 103(2):435-8. PubMed ID: 16677691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunohistochemical study of a flat epithelial antigen and prospects for using it as a marker for squamous cell carcinoma].
    Ievleva ES; Shcherbitskaia IIa; Samratova SS; Marshutina NVa IIa; Pugachev KK
    Biull Eksp Biol Med; 1995 Feb; 119(2):209-11. PubMed ID: 7670057
    [No Abstract]   [Full Text] [Related]  

  • 53. DDx and management of tumors and tumor-like genital lesions.
    Hoppmann HJ
    Geriatrics; 1981 May; 36(5):137-42. PubMed ID: 7194204
    [No Abstract]   [Full Text] [Related]  

  • 54. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Al-Shagahin H; Alkotyfan K; Müller HH; Sesterhenn AM; Werner JA
    Anticancer Res; 2009 Aug; 29(8):3421-5. PubMed ID: 19661367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Squamous cell carcinoma of penis presenting as groin metastasis 3 years before the primary.
    Sinha M; Katema M; Malata CM
    J Plast Reconstr Aesthet Surg; 2006; 59(5):547-9. PubMed ID: 16631563
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinoma of the penis.
    Moore DJ; Fallon B
    Ir Med J; 1981 Feb; 74(2):49-50. PubMed ID: 7228619
    [No Abstract]   [Full Text] [Related]  

  • 58. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tumor marker, biomarker].
    Nawata S; Sueoka K; Sugino N
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():167-70. PubMed ID: 23156236
    [No Abstract]   [Full Text] [Related]  

  • 60. [Remarkably reduced tumor marker SCC levels by combined chemotherapy of paclitaxel and S-1 in two cases of advanced cervical cancer].
    Takagi K; Kougo H; Aoyagi Y; Yonehara T; Minobe S; Azuma M; Yamaguchi T
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):335-7. PubMed ID: 18281778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.